StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Stock Performance
Shares of NASDAQ RKDA opened at $5.11 on Friday. The firm’s 50 day moving average price is $5.01 and its 200-day moving average price is $3.78. The company has a market cap of $6.95 million, a PE ratio of -1.19 and a beta of 0.90. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31.
Arcadia Biosciences Company Profile
See Also
- Five stocks we like better than Arcadia Biosciences
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Election Stocks: How Elections Affect the Stock Market
- What Does the Future Hold for Eli Lilly?
- What Are Dividends? Buy the Best Dividend Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.